Research & Development

在线播放欧美性爱在线a欧美免费教育股受捧 21世纪教育飙升8%新东方在线上升3%


  雲瑯點點頭道︰“你再問問同袍,誰家有這樣的書,就給我送來,我可以不要錢幫他修整甲冑跟武器!”   漢人最討厭的毛病就是顯擺……在线播放 第一零八章 大漢國無自由欧美性爱   那些被雲家收攏的婦人們,還是會源源不斷的往雲家帶人,帶東西,而雲家的男性壯勞力,依舊是——三人!   一個穿著綠衣服的紈褲話還沒有說完,就被霍去病跟李敢兩人提著手腳給丟出去了。在线a欧美免费   “我很干淨!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo